Kintara Therapeutics, Inc (KTRA) PT Raised to $7 at Aegis Capital
Tweet
Share
E-mailGet Alerts KTRA Hot Sheet
Price: $2.08 -0.95%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 50
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 50
Trade Now!
Join SI Premium – FREE
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Aegis Capital analyst Nathan Weinstein raised the price target on Kintara Therapeutics, Inc (NASDAQ: KTRA) to $7.00 (from $6.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CLSA Downgrades Astro Malaysia (ASTRO:MK) to Sell (5)
- Morgan Stanley Upgrades BHP (BHP:LN) (BHP) to Overweight
- BlueScope Steel Limited (BSL:AU) (BLSFY) PT Raised to AUD29 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
